Journal of Internal Medicine Concepts & Practice >
Study on correlation between thyroid hormone levels and cardiac function in type 2 diabetes mellitus patients
Received date: 2023-08-10
Online published: 2024-07-08
Objective To determine the relationship between thyroid hormones levels and cardiac function and structure in type 2 diabetes mellitus (T2DM) patients with normal thyroid function. Methods Totally 526 cases of T2DM patients with normal thyroid function were enrolled, and their information including gender, age, course of disease, blood pressure, blood lipids, liver and kidney functions, and thyroid function were collected; Color diagnostic ultrasound equipment was used to analyze the structure and function of the heart. Results Compared with the male group, the indexes including total cholesterol(TC), high density lipoproteincholesterol (HDL-C), low density lipoproteincholesterol(LDL-C), left ventricular ejection fraction(LVEF), and thyroid stimulating hormone(TSH) were significantly higher in the female group, while the indexes including height, weight, hemoglobin(Hb), blood urea nitrogen(BUN), creatinine(Cr), uric acid(UA), left atrial diameter (LAD), interventricular septum thickness(IVST), left ventricular end diastolic diameter (LVEDD), left ventricular posteriorwall thickness(LVPWT), left ventricular end systolic diameter(LVESD), aortic root diameter(AORD), free triiodothyronine(FT3), and free thyroxine(FT4) were significantly lower in the female group (all P<0.05). Correlation analysis showed that FT3 was positively correlated with LVPWT, LVESD and AORD in the general population (all P<0.05 ). In the male group, TSH was positively correlated with LVESD; in female group, FT3 was positively correlated with LAD and LVESD, and FT4 was negatively correlated with LVEF(P<0.05). Multiple linear regression analysis showed that for female patients, FT3 was an independent fact of LVESD, as the other independents factors, which were age, duration of diabetes, body mass index (BMI), glycosylated hemoglobin, diastolic blood pressure and systolic blood pressure. Conclusions For T2DM patients with normal thyroid function, as the increase of circulating thyroid hormones, LVPWT and LVESD increase. Multiple regression analysis showed that FT3 was independently and positively correlated with cardiac structure in female patients. These results indicate that thyroid hormone levels in patients with T2DM might have an impact on the heart changes even if they are within the normal range.
CHEN Junxiu, SHI Qun, QIN Li, WU Yiming . Study on correlation between thyroid hormone levels and cardiac function in type 2 diabetes mellitus patients[J]. Journal of Internal Medicine Concepts & Practice, 2024 , 19(02) : 95 -101 . DOI: 10.16138/j.1673-6087.2024.02.02
[1] | Wang L, Peng W, Zhao Z, et al. Prevalence and treatment of diabetes in China, 2013-2018[J]. JAMA, 2021, 326(24):2498-2506. |
[2] | Raghavan S, Vassy JL, Ho YL, et al. Diabetes mellitus-related all-cause and cardiovascular mortality in a national cohort of adults[J]. J Am Heart Assoc, 2019, 8(4):e11295. |
[3] | Gregg EW, Hora I, Benoit SR. Resurgence in diabetes-related complications[J]. JAMA, 2019, 321(19):1867-1868. |
[4] | Joubert M, Manrique A, Cariou B, et al. Diabetes-related cardiomyopathy: the sweet story of glucose overload from epidemiology to cellular pathways[J]. Diabetes Metab, 2019, 45(3):238-247. |
[5] | Klein I, Danzi S. Thyroid disease and the heart[J]. Circulation, 2007, 116(15):1725-1735. |
[6] | Eom YS, Wilson JR, Bernet VJ. Links between thyroid disorders and glucose homeostasis[J]. Diabetes Metab J, 2022, 46(2):239-256. |
[7] | Vargas-Uricoechea H, Sierra-Torres CH. Thyroid hormones and the heart[J]. Horm Mol Biol Clin Investig, 2014, 18(1):15-26. |
[8] | Roef GL, Rietzschel ER, van Daele CM, et al. Triiodothyronine and free thyroxine levels are differentially associated with metabolic profile and adiposity-related cardiovascular risk markers in euthyroid middle-aged subjects[J]. Thyroid, 2014, 24(2):223-231. |
[9] | Xu R, Huang F, Zhang S, et al. Thyroid function, body mass index, and metabolic risk markers in euthyroid adults[J]. BMC Endocr Disord, 2019, 19(1):58. |
[10] | Neves JS, Fontes-Carvalho R, Borges-Canha M, et al. Thyroid hormones within the normal range and cardiac function in the general population[J]. Eur Thyroid J, 2021, 10(2):150-160. |
[11] | Zhu P, Lao G, Chen C, et al. TSH levels within the normal range and risk of cardiovascular and all-cause mortality among individuals with diabetes[J]. Cardiovasc Diabetol, 2022, 21(1):254. |
[12] | Sun H, Saeedi P, Karuranga S, et al. IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045[J]. Diabetes Res Clin Pract, 2022,183:109119. |
[13] | Osuna PM, Udovcic M, Sharma MD. Hyperthyroidism and the heart[J]. Methodist Debakey Cardiovasc J, 2017, 13(2):60-63. |
[14] | Udovcic M, Pena RH, Patham B, et al. Hypothyroidism and the heart[J]. Methodist Debakey Cardiovasc J, 2017, 13(2):55-59. |
[15] | Neves JS, Fontes-Carvalho R, Borges-Canha M, et al. Association of thyroid function, within the euthyroid range, with cardiovascular risk[J]. Front Endocrinol (Lausanne), 2022,13:1067801. |
[16] | Biondi B, Palmieri EA, Lombardi G, et al. Effects of thyroid hormone on cardiac function: the relative importance of heart rate, loading conditions, and myocardial contractility in the regulation of cardiac performance in human hyperthyroidism[J]. J Clin Endocrinol Metab, 2002, 87(3):968-974. |
[17] | Prisant LM, Gujral JS, Mulloy AL. Hyperthyroidism: a secondary cause of isolated systolic hypertension[J]. J Clin Hypertens (Greenwich), 2006, 8(8):596-599. |
[18] | Pop?awska-Kita A, Siewko K, Telejko B, et al. The changes in the endothelial function and haemostatic and inflammatory parameters in subclinical and overt hyperthyroidism[J]. Int J Endocrinol, 2013, 2013:981638. |
[19] | Pop?awska-Kita A, Szelachowska M, Modzelewska A, et al. Endothelial dysfunction in Graves’ disease[J]. Adv Med Sci, 2013, 58(1):31-37. |
[20] | Cikim AS, Oflaz H, Ozbey N, et al. Evaluation of endothelial function in subclinical hypothyroidism and subclinical hyperthyroidism[J]. Thyroid, 2004, 14(8):605-609. |
[21] | Konukoglu D, Uzun H. Endothelial dysfunction and hypertension[J]. Adv Exp Med Biol, 2017, 956:511-540. |
[22] | Gu Y, Zheng L, Zhang Q, et al. Relationship between thyroid function and elevated blood pressure in euthyroid adults[J]. J Clin Hypertens (Greenwich), 2018, 20(10):1541-1549. |
[23] | Xu R, Huang F, Zhang S, et al. Thyroid function, body mass index, and metabolic risk markers in euthyroid adults[J]. BMC Endocr Disord, 2019, 19(1):58. |
[24] | Vargas-Uricoechea H, Bonelo-Perdomo A, Sierra-Torres CH. Effects of thyroid hormones on the heart[J]. Clin Investig Arterioscler, 2014, 26(6):296-309. |
[25] | Razvi S, Jabbar A, Pingitore A, et al. Thyroid hormones and cardiovascular function and diseases[J]. J Am Coll Cardiol, 2018, 71(16):1781-1796. |
[26] | Klein I, Danzi S. Thyroid disease and the heart[J]. Circulation, 2007, 116(15):1725-1735. |
[27] | Chen YC, Hsing SC, Chao YP, et al. Clinical relevance of the LVEDD and LVESD trajectories in HF patients with LVEF < 35[J]. Front Med (Lausanne), 2022,9:846361. |
[28] | Tribouilloy C, Grigioni F, Avierinos JF, et al. Survival implication of left ventricular end-systolic diameter in mitral regurgitation due to flail leaflets a long-term follow-up multicenter study[J]. J Am Coll Cardiol, 2009, 54(21):1961-1968. |
[29] | Jabbar A, Pingitore A, Pearce SH, et al. Thyroid hormones and cardiovascular disease[J]. Nat Rev Cardiol, 2017, 14(1):39-55. |
[30] | Kjaergaard AD, Marouli E, Papadopoulou A, et al. Thyroid function, sex hormones and sexual function[J]. Eur J Epidemiol, 2021, 36(3):335-344. |
[31] | Chen L, Zhang M, Xiang S, et al. Association between thyroid function and body composition in type 2 diabetes mellitus (T2DM) patients[J]. Med Sci Monit, 2021,27:e927440. |
[32] | Yeon SB, Salton CJ, Gona P, et al. Impact of age, sex, and indexation method on MR left ventricular reference values in the Framingham Heart Study offspring cohort[J]. J Magn Reson Imaging, 2015, 41(4):1038-1045. |
[33] | Petitto M, Esposito R, Sorrentino R, et al. Sex-specific echocardiographic reference values: the women's point of view[J]. J Cardiovasc Med (Hagerstown), 2018, 19(10):527-535. |
[34] | Brahmbhatt Y, Gupta M, Hamrahian S. Hypertension in premenopausal and postmenopausal women[J]. Curr Hypertens Rep, 2019, 21(10):74. |
[35] | 陈玉莹. 实时三维超声心动图评价绝经前后女性的左心功能[D]. 大连医科大学, 2022. |
/
〈 |
|
〉 |